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Myelin formation during peripheral nervous system
(PNS) development, and reformation after injury and
in disease, requires multiple intrinsic and extrinsic
signals. Akt/mTOR signaling has emerged as a major
player involved, but the molecular mechanisms and
downstream effectors are virtually unknown. Here,
we have used Schwann-cell-specific conditional
gene ablation of raptor and rictor, which encode
essential components of the mTOR complexes 1
(mTORC1) and 2 (mTORC2), respectively, to demon-
strate that mTORC1 controls PNS myelination during
development. In this process,mTORC1 regulates lipid
biosynthesis via sterol regulatory element-binding
proteins (SREBPs). This course of action is mediated
by the nuclear receptor RXRg, which transcriptionally
regulates SREBP1c downstream of mTORC1.
Absence of mTORC1 causes delayed myelination
initiation as well as hypomyelination, together with
abnormal lipid composition and decreased nerve
conduction velocity. Thus, we have identified the
mTORC1-RXRg-SREBP axis controlling lipid biosyn-
thesis as a major contributor to proper peripheral
nerve function.
INTRODUCTION
Themyelin sheath has evolved to enable rapid saltatory propaga-
tion of nerve signals, a crucial feature of the vertebrate nervous
system. In the peripheral nervous system (PNS), Schwann cells
synthesize myelin consisting of tightly compacted layers of
plasma membranes around large caliber axons. The particular646 Cell Reports 9, 646–660, October 23, 2014 ª2014 The Authorsfunctional capabilities of the resulting structure depend mainly
on its geometry and the specialized protein and high lipid con-
tents of the myelin. Impairments of the myelinated Schwann
cell-axon unit due to gene mutations, altered metabolism, or
inflammation are frequent causes of diseases, attesting to the
crucial importance of PNSmyelination (Dyck and Thomas, 2005).
The development of Schwann cells, from immature cells via
the promyelinating state to fully myelinating Schwann cells, re-
quires a multitude of regulatory signals. Many of these steps,
including cell differentiation, myelination initiation, and determi-
nation of the thickness of the myelin sheath, are controlled by
the key regulator neuregulin-1 (NRG1) type III, present on the
axonal surface (Newbern and Birchmeier, 2010). Mediated by
binding to ErbB2/ErbB3 tyrosine kinase receptors on Schwann
cells, NRG1 activates secondmessenger cascades, most prom-
inently the PI3K/Akt, MAPK, and PLCg pathways (Nave, 2010;
Pereira et al., 2012). PI3K/Akt signaling plays a central role in
PNS myelination, because Akt in Schwann cells is required for
correct myelin sheath thickness (Cotter et al., 2010). In addition,
Schwann cell-specific genetic deletion or expression knock-
down of the PIP3 phosphatase PTEN (phosphatase and tensin
homolog), a negative regulator of Akt activity, resulted in
increased Akt phosphorylation and caused hypermyelination
(Cotter et al., 2010; Goebbels et al., 2012). In contrast, overex-
pression of constitutively active Akt in Schwann cells had no
detectable effects on PNS myelination (Flores et al., 2008).
Although this apparent discrepancy waits to be fully resolved,
themTOR (mammalian [or alsomechanistic] target of rapamycin)
pathway has been implicated as a major effector of Akt in myeli-
nation control (Norrme´n and Suter, 2013). Consistent with this
notion, mice lacking the mTOR kinase in Schwann cells have hy-
pomyelinated sciatic nerves (Sherman et al., 2012).
The mTOR pathway is intimately linked with Akt signaling
and forms a major signaling hub in most cell types. It integrates
intra- and extracellular cues, such as nutrients, growth factors,
and energy, which are necessary for cell growth, proliferation,
and metabolism (Cornu et al., 2013; Laplante and Sabatini,
2012). mTOR is the core kinase in two structurally and function-
ally distinct protein complexes, mTOR complex 1 (mTORC1) and
mTORC2. In addition tomTOR, these complexes contain several
adaptors, including the highly conserved and functionally essen-
tial proteins raptor (in mTORC1) and rictor (in mTORC2). Targets
of mTORC1 include S6K1 (ribosomal S6 kinase 1) and 4E-BP1
(eukaryotic initiation factor 4E-binding protein 1), controlling pro-
cesses such as ribosomal biogenesis and cap-dependent trans-
lation. mTORC2 regulates cytoskeletal organization, cell survival
and metabolism through phosphorylation and activation of AGC
kinases, including Akt, SGK1 (serum and glucocorticoid-regu-
lated kinase 1) and PKC (protein kinase C). Akt, which, in addition
to its phosphorylation by mTORC2, is also phosphorylated and
activated by PDK1 (3-phosphoinositide dependent protein ki-
nase 1), in turn, activates mTORC1.
Although Akt/mTOR signaling is evidently essential for myeli-
nation, the downstream effectors and the underlying molecular
mechanisms of this process remain poorly understood. More-
over, because mTOR activity is functionally divided between
mTORC1 and mTORC2, previous studies have not distinguished
between these different parts of the pathway (Sherman et al.,
2012). Thus, we sought to determine the functional roles of the in-
dividual mTOR complexes in the regulation of PNS myelination,
and to identify contributors to the molecular basis of mTOR-
dependent myelination. To this end, we have analyzed the roles
of mTORC1 and mTORC2 functions in the developing mouse
PNSby conditionally deleting raptor, rictor, or both together, spe-
cifically in Schwann cells. We found that signaling by mTORC1 is
critical for PNSmyelination, including timely myelination initiation
and extent of myelination. Control of lipid synthesis via SREBP
transcription factors, including mTORC1-dependent control of
SREBP1c gene expression by the nuclear receptor RXRg, was
identified as a key component in this process.
RESULTS
Loss of Raptor, but Not Rictor, Leads to Impaired
Initiation, and Extent of Myelination but Does Not Affect
Differentiation to Promyelinating Schwann Cells
To study the functions of mTORC1 and mTORC2 during PNS
myelination, we generated mouse mutants lacking raptor
(mTORC1), or rictor (mTORC2), or both raptor and rictor, in
Schwann cells. To this effect, we crossed mice carrying floxed
alleles of raptor and/or rictor (Bentzinger et al., 2008; Polak
et al., 2008) with mice expressing Cre-recombinase under con-
trol of the Desert hedgehog (Dhh) promoter (Jaegle et al.,
2003). First, we verified the specific loss of raptor and/or rictor
proteins in the corresponding mouse mutants by western blot
analysis of sciatic nerve lysates at postnatal day (P) 5 (Fig-
ure S1A). Residual amounts of protein are likely from nonrecom-
bined fibroblast and neurons of the nerves. We then assessed
morphological consequences in the mutant nerves. Analyses
of toluidine-blue-stained semithin cross-sections of P60 sciatic
nerves revealed robustly reduced nerve sizes in raptor mutants
and raptor/rictor double mutants, compared to control nerves,
whereas rictor mutant nerves were indistinguishable from con-Ctrols (Figure 1A). Closer inspection revealed modest reductions
of myelinated axon numbers per nerve and in the area covered
by myelinated axons, whereas axon density was increased in
raptor and raptor/rictor mutants (Figures 1A and S1B). Evalua-
tions of mean axon diameters uncovered a decrease in raptor
and raptor/rictor mutants (Figure 1A), a finding mainly explained
by the absence of large caliber axons (above 6 mm) in these
nerves (Figures 1A and 1B). Detailed size distribution analysis
did not yield major differences in other size categories, beyond
a slight increase in smaller to middle-sized axons in raptor and
raptor/rictor mutants (Figure 1A). The most striking feature
found, however, was substantial hypomyelination in sciatic
nerves of raptor and raptor/rictor mutants, quantitatively con-
firmed by the determination of g-ratios (ratio of axon diameter
divided by fiber diameter) (Figure 1B). Axons of all calibers ex-
hibited thinner myelin sheaths in these mutants, whereas axons
of rictor mutants showed normal myelin thickness (Figure 1B).
Thinner myelin was already evident in raptor and raptor/rictor
mutants at P5, when most Schwann cells had just started to
myelinate (Figures 1C and S1C). G-ratio quantifications in raptor
mutant and control nerves analyzed over time (P5 to 12 months)
revealed the largest difference in myelin at P60, when develop-
mental myelination is essentially complete. Of note, as raptor
mutants got older, myelin slowly continued to grow, as indicated
by significantly decreased g-ratios at 6 and 12 months of age
compared to P60. However, myelin thickness in raptor mutants
never reached that of control mice, at least until 12 months of
age, the last time point examined. Thus, despite continued
myelin growth in raptor mutants, full recovery was not achieved.
Hypomyelination in raptor mutants was not restricted to distal
nerves, or motor or sensory fibers, because this feature was
also evident in both dorsal and ventral roots, containing only sen-
sory or motor fibers, respectively (Figure S1D). Moreover, anal-
ysis of teased nerve fibers revealed decreased internodal
lengths in raptor mutants (Figure S1E), indicating that loss of
raptor affects longitudinal as well as radial Schwann cell growth,
consistent with previous findings in mTOR-deficient Schwann
cells (Sherman et al., 2012).
During nerve development, immature Schwann cells envelop
bundles of axons. Subsequently, these cells single out large
caliber axons in a radial sorting process, establishing a 1:1 rela-
tionship as promyelinating Schwann cells surrounding individual
axons (reviewed in Jessen and Mirsky, 2005). At P5, raptor
mutant and littermate control nerves had a similar number of pro-
myelinating Schwann cells (Figure 2A, yellow arrowheads),
consistent with equal staining for the promyelinating marker
Oct6 (Figure 2B) and equal Oct6 protein levels determined by
western blotting (Figure 2C). These results indicate that differen-
tiation from immature to promyelinating Schwann cells is not
majorly affected in raptor mutant nerves. However, at P14,
when all promyelinating Schwann cells in control or rictor mutant
nerves had started to myelinate, raptor and raptor/rictor mutant
nerves still contained high numbers of Schwann cells left in a
promyelinating state (Figures 2A and 2B and S2A), indicating a
delay in the onset of myelination. At P60, the transition block
from the promyelinating to myelinating state had been over-
come, because highly Oct6-expressing cells or 1:1 relationships
were no longer present (data not shown).ell Reports 9, 646–660, October 23, 2014 ª2014 The Authors 647
Figure 1. PNS Hypomyelination in Mouse Nerves Lacking Raptor in Schwann Cells
(A) Toluidine-blue-stained semithin sections of sciatic nerves from control (Ctrl), rictor (Rict), raptor (Rapt), and raptor/rictor (Rapt/Rict) mutant mice at P60,
showing smaller nerves in raptor and raptor/rictor mutants. Scale bar, 50 mm. Nerve area, numbers, and mean axon diameter of all myelinated axons in the main
fascicle were quantified, showing a significant decrease in nerve area, slightly fewer myelinated axons, and smaller mean axon diameter. Percentual distribution
of axon diameters is shown divided in six size classes. Results are the mean from three different mice per genotype. Error bars: SEM. *p < 0.05, ***p < 0.001.
(B) EM micrographs of ultrathin cross-sections of sciatic nerves from control, rictor, raptor, and raptor/rictor mutant mice at P60, showing hypomyelination in
raptor and raptor/rictor mice. Scale bar, 5 mm. Myelin thickness was quantified as g-ratio (axon diameter divided by fiber diameter) and plotted against the axon
(legend continued on next page)
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Figure 2. Loss of Raptor Causes Delayed
Onset of Myelination
(A) EM micrographs of ultrathin cross-sections of
sciatic nerves from control and raptor mutant mice
at P5 and P14, showing similar numbers of pro-
myelinating Schwann cells in a 1:1 relation with
axons (yellow arrowheads) in raptor mutants and
controls at P5. At P14, there is persistence of 1:1
relations in mutants, whereas in controls all
Schwann cells have progressed to a myelinating
state (except those in Remak bundles). Insets
show examples of 1:1 Schwann cell-axon units.
Scale bar, 5 mm.
(B) Oct6 immunostaining of transverse cry-
osections from control and raptor mutant sciatic
nerves at P5 and P14, showing similar numbers of
Oct6-expressing cells in raptor mutants and con-
trols at P5, whereas at P14 there is continued high
Oct6 expression only in raptor mutants, indicative
of a delay in the onset of myelination. Scale bar,
50 mm.
(C) Western blot analysis of myelin proteins in
sciatic nerve lysates from control, rictor, raptor,
and raptor/rictor mutant mice at P5. Expression
levels from at least three mice per genotype were
quantified, and average levels are shown relative
to control mice. Error bars: SEM. *p < 0.05.
See also Figure S2.Raptor mutants also showed defects in radial sorting and Re-
mak bundle formation, with large immature bundles still present
at P60 (Figure S2B). In controls and rictor mutants all large caliber
axonshadbeensortedout fromthematuringbundlesprior toP14,
leavingonlymatureRemakbundlesassociatedwithnonmyelinat-
ingSchwanncells (FigureS2B). In raptormutants,Remakbundles
with regular morphology could not be found even at P60. Instead,
the bundles present were abnormally large (although smaller than
at P14, see quantification in Figure S2B), containing axons of
mixed calibers without Schwann cell cytoplasm between individ-
ual axons, similar to previous reports describing radial sorting de-
fects (Pellegatta et al., 2013; Pereira et al., 2009). At 6 months,
bundles in raptor mutants were considerably smaller and had
taken a more Remak bundle-like structure, where Schwann cell
cytoplasm was present around some of the axons (Figure S2B).
Analyses of 8-month-old sympathetic trunks with an enrichment
of small caliber axons andRemak bundleswere in linewith the re-
sults from sciatic nerves, demonstrating that raptor mutants with
time can form Remak bundle-like structures, albeit with fewer
axons and abnormal morphology (Figure S2C).
Next, we studied the expression of major myelin proteins and
transcription factors in sciatic nerves during active myelination.diameter. Note the absence of large caliber axons in raptor and raptor/rictor mut
mice for each genotype. Error bars: SEM. **p < 0.01.
(C) EM micrographs of ultrathin cross-sections of sciatic nerves from control an
hypomyelination in raptor mutants already at P5, and lasting at least until 12 mont
bar, 5 mm. Myelin thickness was quantified as the g-ratio. At least 100 axons per a
**p < 0.01, ***p < 0.001.
See also Figure S1.
CAt P5, MBP and P0 protein levels were modestly reduced in
raptor/rictor double mutants compared to controls, with a similar
trend also in raptor mutants, whereas MAG was unaltered (Fig-
ure 2C). No major changes in protein expression of main tran-
scriptional regulators of the PNS myelination program, Sox10,
Krox20, and Oct6, were observed in any mutants at this stage
(Figure 2C; data not shown).
Taken together, our data show that raptor/mTORC1 in
Schwann cells is a critical regulator of myelination initiation and
myelin growth in the PNS. Because these processes were not
detectably altered in Schwann cells lacking rictor/mTORC2, we
conclude that functional mTOR signaling in developing myelinat-
ing Schwann cells is predominantly mediated by mTORC1,
similar to recent findings in oligodendrocytes (Bercury et al.,
2014; Lebrun-Julien et al., 2014).
Altered Signaling due to Inactivation of raptor or rictor
Affects Akt Activation
To elucidate signaling pathways affected in nerves of the mutant
mice, we analyzed the signaling downstream of mTORC1 and
mTORC2. As expected, 4E-BP1 and S6K, common phosphory-
lation targets of mTORC1, were hypophosphorylated in raptorants (arrow in g-ratio plot). At least 100 axons per animal were analyzed. n = 3
d raptor mutant mice at P5, P60, 6 months, and 12 months of age, showing
hs of age. The hypomyelination becomes less severe with age (past P60). Scale
nimal were analyzed. n = 3 mice for each genotype. Error bars: SEM. *p < 0.05,
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Figure 3. Decreased mTORC1 Signaling and Increased Akt Phos-
phorylation in Raptor Mutant Mice
(A) Western blot analysis of phosphorylation status of mTORC1 and mTORC2
targets in sciatic nerve lysates from control, rictor, raptor, and raptor/rictor
mutant mice at P5. Expression levels of at least three mice per genotype were
quantified, and average levels are shown relative to control mice. Error bars:
SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
(B) Western blot analysis of sciatic nerve lysates from control and raptor
mutant mice at P5, showing no significant differences in ErbB2 or Erk1/2
phosphorylation. Expression levels from at least threemice per genotype were
quantified, and average levels are shown relative to control mice. Error bars:
SEM.
See also Figure S3.and raptor/rictor mutants, but not in rictor mutants (Figure 3A).
Furthermore, P-Akt (T308), which is phosphorylated by PDK1,
was strongly hyperphosphorylated in raptor and raptor/rictor
mutants (Figure 3A). This finding is likely due to the absence
of negative feedback loops that normally act downstream of
mTORC1/S6K1 to ensure inhibition of upstream growth factor
signaling upon prolonged or excessive mTORC1 activity (Efeyan
and Sabatini, 2010). The mTORC2 target P-Akt (S473) was
strongly decreased in rictor and raptor/rictor mutants, consistent
with the loss of the functionally required mTORC2 component650 Cell Reports 9, 646–660, October 23, 2014 ª2014 The Authorsrictor. In raptor mutants, however, P-Akt (S473) was hyperphos-
phorylated, suggesting that loss of the negative feedback loops
downstream of mTORC1/S6K in raptor mutants also affects
mTORC2 activity. Of note, the Akt species recognized by anti
P-Akt (T308) antibodies migrated slightly faster in SDS gel anal-
ysis of sciatic nerve lysates of rictor mutants (and of raptor/rictor
mutants) (Figure 3A), consistent with previous observations
(Sherman et al., 2012). This finding points to differences in Akt
isoforms expressed or, more likely, posttranslational modifica-
tions (such as differential phosphorylation of sites other than
T308 and S473) in nerves lacking rictor.
Based on the defects observed in Schwann cell myelination in
raptor mutants, we looked for alterations in known signaling
pathways regulating these processes. We detected no differ-
ences in the activation of the ErbB2/ErbB3 receptor complex
(P-ErbB2/ErbB2) or the activation of the MAPK pathway at the
level of Erk signaling (P-Erk1/2/Erk1/2) (Figure 3B), or in protein
levels of PTEN, integrin b1, and ILK in raptor mutants compared
to controls (Figure S3).
Loss of mTORC1 Activity in Schwann Cells Leads
to Defective SREBP Signaling
During myelination, the Schwann cell membrane expands
several thousand-fold (Webster, 1971), requiring high amounts
of lipid biosynthesis. The sterol regulatory element-binding pro-
teins (SREBPs) are transcription factors that regulate expres-
sion of the majority of enzymes necessary for fatty acid and
cholesterol synthesis, with SREBP1c mainly regulating enzymes
of the fatty acid synthesis pathway and SREBP2 primarily
cholesterol synthesis enzymes (Shao and Espenshade, 2012).
SREBPs are synthesized as inactive full-length precursors
bound to SCAP (SREBP cleavage-activating protein) and INSIG
(insulin-induced gene) in the endoplasmic reticulum (ER) (Shao
and Espenshade, 2012). In a sterol-dependent fashion, the
SREBPs are transported to the Golgi for proteolytic processing.
Once cleaved, mature SREBPs enter the nucleus to act as tran-
scription factors. mTOR signaling regulates SREBP activity in
various cell types in a variety of ways (Bakan and Laplante,
2012; Porstmann et al., 2008). SCAP, in turn, is required for
proper PNS myelination (Verheijen et al., 2009). Thus, we
analyzed expression of SREBP1 and SREBP2 in mTORC1-
and mTORC2-deficient nerves. Indeed, protein levels of full-
length SREBP1 were reduced in raptor and raptor/rictor
mutants, as were SREBP1c mRNA levels, whereas rictor mu-
tants expressed levels comparable to controls (Figure 4A).
Also, the SREBP1 target genes FASN (fatty acid synthase)
and SCD1 (stearoyl-CoA desaturase 1) were strongly downre-
gulated in raptor nerves both at the protein and mRNA levels
(Figures 4A and 4B), whereas rictor mutant nerves showed pro-
tein levels equal to controls. These findings indicate that
SREBP1 transcription and activity are decreased in mTORC1-
deficient but not mTORC2-deficient nerves. However, neither
protein levels of full-length SREBP2 nor SREBP2 transcripts
were reduced in raptor mutants, despite that the SREBP2 target
proteins HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase)
and IDI1 (isopentenyl-diphosphate delta isomerase 1) were
strongly downregulated both at the protein and mRNA levels
(Figures 4A and 4B). These results indicate that SREBP2 activity
Figure 4. Deficient mTORC1 Activity Leads to Decreased SREBP Signaling
(A) Western blot analysis of SREBP proteins and their targets in sciatic nerve lysates from control, rictor, raptor, and raptor/rictor mutant mice at P8, showing
decreased full-length SREBP1, FASN, and SCD1 expression. Expression of full-length SREBP2 is not changed, although its targets HMGCR and IDI1 are
downregulated. The expression in at least threemice per genotype was quantified and is shown as average values normalized to those in control mice. Error bars:
SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
(B) qRT-PCR analysis of SREBPs and their target gene expression in sciatic nerve lysates from control and raptor mutant mice at P8, shown as relative transcript
levels compared to controls. ThemRNA levels of target genes of SREBP1c and SREBP2 are reduced, as are SREBP1c levels themselves, whereas SREBP1a and
SREP2 levels are comparable to those in control mice. n = 4 mice for each genotype. Error bars: SEM. ***p < 0.001.
(C) Immunostaining for FASN (green) and the myelin marker MBP (red) in transverse cryosections from control and raptor mutant sciatic nerves at P14, showing
loss of FASN in raptor mutant Schwann cell cytoplasm. Immunostaining for the Schwann cell cytoplasm marker S100 (pseudo-colored in green) in separate
sections shows that the cytoplasmic compartment of raptor mutant Schwann cells appears normal. Scale bar, 5 mm.
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Figure 5. Abnormal Lipid Composition in
Nerves of Raptor Mutant Mice
Lipid extracts of P60 sciatic nerves from control
and raptor mutant mice were analyzed using liquid
chromatography-mass spectrometry for nones-
sential and essential fatty acids (N.ess FA; Ess. FA)
and all major lipid classes (CHOL, cholesterol; PC,
phosphatidylcholine; PE, phosphatidylethanol-
amine; PI, phosphatidylinositol; SM, sphingo-
myelin; CER, ceramide; GSL, glycosylceramide).
n = 3 animals for control mice, n = 4 for raptor
mutant mice. Error bars: SEM. *p < 0.05, **p <
0.01, ***p < 0.001. See also Figure S4.
(A) Amounts of each lipid class normalized to total
protein content.
(B and C) Percentage of saturated fatty acids
(FA), monounsaturated FAs (MUFA), and poly-
unsaturated FAs (PUFA) among total FAs, as well
as the ratio between MUFA 18:1 and essential
PUFA 18:2, indicating a shift from MUFAs to
PUFAs in raptor mutants.
(D) Percentage of indicated FAs compared to total
FAs. FA 18:1, the most abundant FA in Schwann
cells, as well as myelin enriched very-long-chain
fatty acids (VLCFA) 22:0 and 24:0, were signifi-
cantly downregulated in raptor mutant nerves.
Levels of essential and conditionally essential FAs
18:2 and 22:6 were instead significantly increased
in raptor mutants.
(E) Examples of individual lipid species containing
FAs 18:1, 18:2, or 22:6, showing that changes in
raptor mutants for these lipids are similar to those
for the FAs they incorporate (shown in D).
See also Figure S4.is decreased in mTORC1-deficient Schwann cells compared to
controls but, unlike SREBP1c, this activity is regulated by post-
transcriptional, likely even posttranslational, mechanisms. No
changes were found in transcript levels for SREBP1a, a minor
SREBP isoform expressed at low levels in Schwann cells (Fig-
ure 4B). Finally, we confirmed by immunohistochemistry on
cross-sections of sciatic nerves that the loss of the SREBP1
target FASN observed in sciatic nerve lysates in raptor mutants
occurred indeed in Schwann cells (Figure 4C).
Collectively, these data demonstrate that loss of raptor/
mTORC1 signaling in Schwann cells leads to defective SREBP
signaling, resulting in downregulation of both SREBP1c
and SREBP2 target genes. The mTORC1 complex regulates
SREBP1c at the transcriptional level, whereas SREBP2 activity
appears to be regulated posttranslationally.652 Cell Reports 9, 646–660, October 23, 2014 ª2014 The AuthorsAberrant Lipid Composition
and Reduced Nerve Conduction
Velocity in Nerves of raptor-
Deficient Mice
The hypomyelination and substantial
downregulation of lipogenic and choles-
terogenic enzymes in raptor mutants
prompted us to analyze the lipid compo-
sition of sciatic nerves of raptor mutants
and controls. As expected, we foundlower levels of cholesterol and nonessential fatty acids (FAs) in
raptor mutant nerves (P60; Figure 5A). Of note, raptor mutants
showed an absolute increase of essential FAs, which cannot
be synthesized by the body and thus require external uptake (Fig-
ures 5A and 5D). Increased uptake of FAs from external sources
is a likely explanation for this finding. In addition to cholesterol
and nonessential FAs, also the amount of total phosphatidylcho-
line (PC) was reduced. Other major lipid constituents of PNS
myelin, such as sphingomyelin (SM), phosphatidylethanolamine
(PE), phosphatidylinositol (PI), glycosylceramide (GSL), and cer-
amide (CER), showed a tendency to be lower in raptor mutants
compared to controls, but without reaching statistical signifi-
cance. Besides the general absolute reduction inmajor lipid clas-
ses and in several individual lipid species when compared to the
protein content of the nerves (Figure S4), also the relative
Figure 6. Reduced Nerve Conduction Velocities in Raptor Mutant
Mice
(A) Representative image of a compound muscle action potential (CMAP)
recording (measuring motor nerve conduction velocity, mNVC) from foot
muscles after proximal stimulation of sciatic nerves from 4-month-old control
and raptor mutant mice. Dotted lines show latency of signals between control
and raptor mutant mice.
(B) Vertical scatterplot showing reduction of mNCV, reduction of compound
sensory NCV (csNCV), and unchanged amplitude and area of CMAPs in sciatic
nerves of raptor mutants. n = 6 mice. mV, millivolt; ms, millisecond; m/s, meter
per second. Data are shown as mean ± SEM. *p < 0.05, ***p < 0.001.distributions of specific FAs and lipid species were altered in
raptor mutants (Figures 5B–5E). There was a shift from monoun-
saturated fatty acids (MUFAs) toward polyunsaturated fatty
acids (PUFA) in raptor mutants (Figure 5B), which was also
seen in the decreased ratio of FAs 18:1 (oleic acid) to 18:2 (lino-
leic acid) (Figure 5C). The nonessential FA 18:1 is the most abun-
dant FA in Schwann cell myelin, whereas FA 18:2 is an essential
FA. Thus, the decreased 18:1/18:2 ratio reflects the decreased
ability of raptor mutants to synthesis FAs. The proportions of
FAs 18:1 and 18:2 change during normal PNS development, re-
flecting accumulation of myelin and providing an index of the
myelination status (Garbay et al., 2000). In line with this notion
and with our results, a decreased 18:1/18:2 ratio has also beenCobserved in other hypomyelinated mouse mutants, such as the
Charcot-Marie-Tooth disease type 1A (CMT1) mouse model
Trembler (Garbay et al., 1998), and in the Schwann cell-specific
SCAP mutant mouse with defective SREBP signaling (Verheijen
et al., 2009). The essential and conditionally essential FAs 18:2
and 22:6 were increased both relative to other FAs and when
normalized to protein content (Figures 5D and S4). Compared
to membranes from other cell types, myelin is specifically en-
riched in saturated very-long-chain fatty acids (VLCFAs)
(22:0 and 24:0). The levels of these FAs were markedly reduced
in raptor mutant sciatic nerves (Figure 5D). Finally, alterations
in the levels of specific FAs were also reflected in altered levels
of the specific lipid species that incorporate these FAs
(Figure 5E).
Myelination of nerves allows saltatory conduction, but correct
myelin assembly and composition are imperative for proper
nerve conduction velocity (NCV). Because we observed signifi-
cantly thinner myelin sheaths and shortened internodes in raptor
mutants, accompanied by an aberrant myelin lipid composition,
we performed NCV studies to examine whether the velocity
would be compromised in the mutant nerves. Both motor nerve
conduction velocity (mNCV) and compound sensory nerve con-
duction velocity (csNCV) were reduced in raptor mutants (Fig-
ure 6A), indicating that both motor and sensory fibers are
affected equally, consistent with our observations that the
ventral and dorsal roots are both hypomyelinated. Moreover,
neither the compoundmuscle action potential (CMAP) amplitude
nor its area was significantly altered (Figure 6B), indicating that
all fibers were affected homogenously and no major axon loss
had occurred.
In conclusion, our data show that loss of raptor/mTORC1 in
Schwann cells leads to abnormal lipid composition of sciatic
nerves. This includes a general decrease in cholesterol, total
fatty acids, and phosphatidylcholines, likely as a result of the
observed decreases in key enzymes involved in fatty acid and
cholesterol synthesis. Furthermore, slowed NCV was found in
raptor mutant mice, in agreement with the observed hypomyeli-
nation, shorter internodes, and changes in lipid composition,
demonstrating that raptor/mTORC1 in Schwann cells is crucial
for proper nerve physiology.
The Nuclear Receptor RXRg Regulates SREBP1c
Downstream of mTORC1
To elucidate how SREBP transcription factors are regulated in
Schwann cells, and how mTORC1 may influence this regulation,
we sought to analyze the SREBP pathway in more detail. The
mTORC1 target S6K has been associated with SREBP regula-
tion downstream of mTORC1 (Du¨vel et al., 2010). Morphologic
analysis of adult sciatic nerves from combined S6K1/2 knockout
mice did not, however, reveal defects in myelin thickness and
structure (Figure S5A). Also the subcellular localization of lipin1
has been implicated in mTORC1-dependent regulation of
SREBP signaling (Peterson et al., 2011). However, immunohisto-
logical staining for lipin1 showed partly nuclear staining in both
control and raptor mutant nerves, without major differences (Fig-
ure S5B). Next, we analyzed gene expression levels of factors
involved in SREBP processing, such as SCAP, INSIG proteins,
and S1P and S2P proteases (Figure S5C), but could not findell Reports 9, 646–660, October 23, 2014 ª2014 The Authors 653
Figure 7. The Nuclear Receptor RXRg Regulates SREBP1c Downstream of mTORC1
(A and B) qRT-PCR analysis expression of liver X and retinoid X nuclear receptors (LXR and RXR) in sciatic nerve lysates from control and raptor mutant mice at
P8, shown asmean relative transcript levels compared to controls. Of the nuclear receptors only RXRg is reduced. n = 4mice for each genotype. Error bars: SEM.
***p < 0.001.
(legend continued on next page)
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likely contributors to the decreased SREBP signaling in raptor
mutants.
The fact that the mRNA level of SREBP1c was substantially
downregulated in raptor mutant nerves (Figure 4B) points to tran-
scriptional regulation as a putative mechanism of how SREBP1c
is regulated downstream of mTORC1. SREBP2 activity was also
decreased in mTORC1-deficient Schwann cells compared to
controls, but, unlike SREBP1c, the mRNA levels were not
changed, and hence SREBP2 is not likely regulated transcription-
ally by mTORC1. In some cell types, the liver X receptors (LXRs),
which aremembers of the nuclear hormone receptor superfamily,
regulate the transcription of Srebf1c (encoding SREBP1c) (Repa
et al., 2000). We therefore analyzed LXR expression levels in
raptor mutant mice. However, mRNA levels of LXRa and LXRb
were not altered compared to controls (Figure 7A). We also
analyzed expression levels of the retinoid X receptors (RXRs), a
related nuclear receptor family known to heterodimerize with
the LXR receptors. Although RXRa and RXRb transcript levels
were unchanged, RXRg mRNA levels were strongly reduced in
raptor mutants (Figure 7B). The amounts of RXRg were also
reduced at the protein level in raptor and raptor/rictor mutants,
whereas rictor mutants had RXRg levels comparable to controls
(Figure 7C). Related nuclear receptors of the retinoic acid recep-
tor (RAR) family were not differentially regulated in raptor mutant
nerves (Figure S5D) (although RARa showed a tendency for in-
crease), nor were other transcriptional regulators implicated in
mTORC1/SREBP signaling, such as YY1 (yin yang 1), PGC-1a
(peroxisome proliferator-activated receptor gamma coactivator
1 alpha), and the NF-Y (nuclear transcription factor Y) family (Fig-
ures S5E and S5F).
We next turned to cell cultures of primary rat Schwann cells to
study the signaling in more detail. In these experiments, knock-
down of raptor using small interfering RNA (siRNA) recapitulated
at large the observations in raptormutantmice (Figure 7D).More-
over, when knocking down RXRg expression, we observed
similar downregulation of SREBP1c and its downstream target
SCD1 as in raptor mutants in vivo and raptor knockdown in vitro
(Figure 7D), suggesting that RXRgmay regulate SREBP1c down-
stream of mTORC1. Consistent with our findings in raptor mutant
nerves,wedidnotobservechanges inSREBP2 transcript levels in
raptor or RXRg knockdown cells. However, whereas raptor
knockdown caused downregulation of the SREBP2 target IDI1
similar as in vivo, RXRg knockdown did not alter IDI1 levels (Fig-(C) Western blot analysis showing reduced RXRg levels in sciatic nerve lysates o
levels in at least three mice per genotype were quantified, and average levels ar
(D) Primary Schwann cells were transfected with a pool of two siRNAs each, or
RXRg, or SREBP1. Expression of indicated genes was analyzed by qRT-PCR, 72
three independent experiments. Error bars: SEM. *p < 0.05, **p < 0.01, ***p < 0.0
(E) Primary Schwann cells were transduced with a lentivirus expressing RXRg or
72 hr after transduction by qRT-PCR. Results are shown as mean ratio versus co
0.01, ***p < 0.001.
(F) Primary Schwann cells were transfected with luciferase constructs and transdu
days later cells were assayed for firefly luciferase activity, and levels were normal
experiments. *p < 0.05.
(G) Primary Schwann cells were first transfected with a pool of siRNAs against r
expressing control virus, and expression of indicated genes was analyzed 72 hr
from three independent experiments. Error bars: SEM. *p < 0.05, **p < 0.01. See F
RXRg in this experiment.
Cure 7D). Together, these results suggest that, whereas mTORC1
regulatesSREBP2activity inSchwanncells, RXRgdoesnot regu-
late SREBP2, but only SREBP1c. To rule out siRNA off-target ef-
fects, knockdown experiments were repeated with a second set
of siRNAs, yielding similar results (Figure S6A). Next, we overex-
pressed RXRg in primary Schwann cells. Consistent with the
knockdown results, this treatment led to markedly increased
levels of SREBP1c transcripts and its target FASN (Figure 7E),
further confirming that RXRg regulates SREBP1c in Schwann
cells. As expected, mRNA levels of SREBP2 and the SREBP2
target IDI1 were not changed (Figure 7E). To confirm that the
RXRg-dependent regulation of SREBP1c was at the transcrip-
tional level, we performed luciferase reporter assays with a re-
porter construct containing a fragment of theSREBP1cpromoter.
As expected, RXRg expression led to activation of the SREBP1c
promoter, as seen by increased luciferase activity (Figure 7F),
thus indicating regulation of SREBP1c transcription in Schwann
cells. The SREBP2 promoter could not be activated by RXRg
overexpression, confirming our results that RXRg does not regu-
late SREBP2 signaling. Finally, to demonstrate that the defective
SREBP1signaling inSchwanncells upon raptor deletion is indeed
due to decreased RXRg, we overexpressed RXRg in Schwann
cells with knocked-down expression of raptor. The results show
that the decreased levels of SREBP1c and FASN transcripts in
raptor knockdown cells could be rescued to similar levels
compared to controls by reintroducing higher RXRg expression
(Figures 7G and S6B), corroborating our results that mTORC1
contributes to the control of lipid biosynthesis by RXRg-depen-
dent transcriptional regulation of SREBP1c.
In conclusion, we have demonstrated that deficient mTORC1
(but not mTORC2) -mediated signaling in Schwann cells leads
to hypomyelination, together with an abnormal lipid profile and
reduced NCV. Furthermore, we found that SREBP1c and
SREBP2 are regulated downstream of mTORC1 in Schwann
cells. SREBP1c is regulated transcriptionally, whereas SREBP2
is controlled by other means. Finally, we have established
RXRg as a transcription factor regulated downstream of
mTORC1 and shown that RXRg controls SREBP1c transcription
and consequently lipidomic enzyme expression in Schwann
cells. Collectively, these data provide a molecular basis for
mTORC1-dependentmyelin production and underline the impor-
tance of mTOR signaling and lipid biosynthesis for correct myeli-
nation in the developing PNS.f raptor and raptor/rictor mutant mice compared to controls at P5. Expression
e shown relative to levels from control mice. Error bars: SEM. **p < 0.01.
a nontargeting siRNA (siControl), to achieve expression knockdown of raptor,
hr posttransfection. Results are shown as mean ratio of siControl levels from
01. See also Figure S6A.
a GFP-expressing control virus. Expression of indicated genes was analyzed
ntrol virus levels from three independent experiments. Error bars: SEM. **p <
cedwith a lentivirus expressing RXRg or a GFP-expressing control virus. Three
ized against Renilla luciferase activity. Error bars: SEM from three independent
aptor, and 5 hr later transduced with a lentivirus expressing RXRg or a GFP-
later by qRT-PCR. Results are shown as mean ratio versus control virus levels
igure S6B for qRT-PCR results of knockdown of raptor and overexpression of
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DISCUSSION
The Akt/mTOR pathway has been implicated as a major player
controlling myelination (Norrme´n and Suter, 2013). Indeed, ge-
netic ablation of mTOR in Schwann cells results in hypomyelina-
tion (Sherman et al., 2012). However, neither the downstream
effectors involved nor the individual roles of the two functionally
distinct mTOR complexes are known. Here, we have deleted
raptor and rictor in Schwann cells, individually or together, lead-
ing to consequent loss of mTORC1 and/or mTORC2 signaling.
This experimental strategy allowed us to determine individual
roles of the mTOR-containing complexes in Schwann cells dur-
ing PNS myelination. Loss of mTORC2 signaling alone had no
detectable impact on Schwann cell differentiation or myelin for-
mation. In contrast, mTORC1 deficiency in Schwann cells, in
both raptor and raptor/rictor mutants, led to profound changes
in peripheral nerves. mTORC1-deficient nerves were consider-
ably smaller compared to controls, despite only a slight decrease
in the number of myelinated axons (possibly due to excessive
numbers of axons still left in large unsorted bundles). Moreover,
we found an absence of large caliber axons (above 6 mm) in
mTORC1-deficient sciatic nerves of young adults. Because
axons may require trophic support from overlaying Schwann
cells (Nave, 2010), similar to recent demonstrations for oligoden-
drocytes and their associated axons (Morrison et al., 2013),
mTORC1-deficient Schwann cells might not be able to provide
sufficient support to allow normal axon growth. Our raptor-defi-
cientmodel provides a promising entry point to elucidate themo-
lecular nature of such support that has been proposed but has
remained largely enigmatic.
Hypomyelination is a major hallmark of mTORC1-deficient
nerves, a feature already evident at the start of myelination.
Althoughmyelin was able to grow slowly in raptor mutants during
adulthood, myelin thickness did not fully recover, because signif-
icant hypomyelination was sustained in 1-year-old mice. In addi-
tion, we found a marked delay in myelination initiation, whereas
mTORC1 deficiency did not affect differentiation of Schwann
cells to the promyelinating state in major ways.
In the search for factors that are responsible for the defective
myelination downstream of mTORC1, attenuation of translation
has to be considered due to the hypophosphorylation of the
mTORC1 downstream targets 4E-BP1 and S6K observed in
mTORC1-deficient nerves. Although such contributions remain
a valid option, we did not find major changes in protein levels
of myelin proteins and myelin regulators in raptor mutants
during active myelination. Instead, our results suggest that
only MBP might be translationally regulated downstream of
mTORC1, in line with recent findings in oligodendrocytes (Ber-
cury et al., 2014; Lebrun-Julien et al., 2014). Moreover, we de-
tected no hypomyelination in adult S6K1/2 double-deficient
mutant mice. Thus, we turned to regulation of lipid biogenesis
as an attractive contributing target that might be critically regu-
lated by mTORC1 during Schwann cell myelination. Indeed, we
found strongly decreased signaling by SREBPs, the central reg-
ulators of lipid synthesis, in raptor mutant nerves. This finding
was accompanied by altered lipid composition and decreased
levels of FAs and cholesterol. In support of a functional link of
these features to proper myelination, hypomyelinated nerves656 Cell Reports 9, 646–660, October 23, 2014 ª2014 The Authorsand decreased FA synthesis were also characteristic of mice
lacking the SREBP regulator SCAP in Schwann cells (Verheijen
et al., 2009). Moreover, similar to raptor mutants, SCAP mutants
showed myelin growth in adulthood, likely due to external lipid
uptake, as also suggested by increased levels of essential
FAs present in raptor mutant nerves. However, the current
knowledge of functional roles of lipids and their relative compo-
sitions in peripheral nerves is still fragmentary. Correct lipid
levels are likely to be required for multiple essential regulatory
processes in peripheral nerves, including Schwann cell
signaling, differentiation, support of axons, trafficking of myelin
proteins, myelin compaction, and establishing electrophysio-
logical characteristics (Chrast et al., 2011). Thus, decreased
lipogenesis and abnormal lipid composition in raptor mutants
may not only contribute to reduced myelin growth, but also to
the observed slowed NCV.
Mice lacking the SREBP-controlled squalene synthase in
Schwann cells, and thus endogenous cholesterol synthesis,
are affected by severe hypomyelination (Saher et al., 2009),
consistent with functional contributions of decreased cholesterol
levels to the hypomyelination in raptor mutants. Control of
cholesterol in Schwann cells has been proposed as a major reg-
ulatory mechanism coordinating and balancing protein and lipid
synthesis during myelination (Pertusa et al., 2007; Quintes et al.,
2010; Saher et al., 2009). According to this hypothesis, low
cholesterol levels lead to reduced transcription of genes encod-
ing major myelin proteins as a potential safety mechanism
guarding against deleterious effects of overexpression of myelin
proteins. Furthermore, the persistence of Schwann cells at the
promyelinating stage in raptor mutant nerves is consistent with
results from mice with defective cholesterol synthesis and sup-
ports the notion that a threshold level of cholesterol is required
for myelination initiation (Saher et al., 2009; Verheijen et al.,
2009).
In addition to disturbed myelination initiation and progression,
raptor mutants also showed persistence of immature, unsorted
axon bundles. With time, the bundle size decreased, and later
in adulthood Remak bundle-like structures appeared, albeit of
abnormal morphology. Whether the defect is purely due to dis-
turbances in radial sorting, or a combination of defective sorting
and differentiation of specifically nonmyelinating Schwann cells,
remains to be explored. However, as nerves from other mouse
models with defective lipid synthesis do not, to our knowledge,
display such a phenotype, the defect in Remak bundle matura-
tion in mTORC1-deficient nerves is likely not due to decreased
SREBP signaling, but rather due to disturbance of other path-
way(s) downstream of mTORC1.
We show here that SREBPs are important downstream medi-
ators of mTORC1 signaling in Schwann cells. Regulation of
SREBPs by the mTOR pathway is known from other cell types,
but the underlying mechanisms are not fully understood. We
found downregulation of SREBP1c, but not of SREBP2, in both
raptor mutant nerves and after raptor knockdown in Schwann
cell cultures. Nevertheless, target genes of both SREBP1c and
SREBP2 were strongly downregulated. Crosstalk between the
SREBP1 and SREBP2 pathways could potentially explain these
findings (Du¨vel et al., 2010). However, overexpression of RXRg in
Schwann cells led to increased levels of SREBP1c transcripts
and its target FASN, whereas the SREBP2 target IDI1 was not
altered. Hence, these findings suggest minimal crosstalk be-
tween the SREBP1 and SREBP2 pathways in Schwann cells.
Our data indicate that in Schwann cells, SREBP1c is transcrip-
tionally controlled downstream of mTORC1, whereas SREBP2
is posttranslationally regulated. SREBPs can be regulated by
mTORC1 at various levels, including induction of SREBP tran-
scription, activation of ER-Golgi translocation, protein process-
ing, posttranslational modifications, and protein stability (Bakan
and Laplante, 2012). The mTORC1 substrate S6K has, in some
settings, been suggested as mediator of SREBP regulation (Du¨-
vel et al., 2010; Owen et al., 2012), but we found no signs of
hypomyelination in adult S6K1/2 mutant mice, rendering a role
for S6K in myelin-related SREBP signaling unlikely. mTORC1-
dependent SREBP regulation is also controlled by nuclear local-
ization of lipin1 (Peterson et al., 2011). However, we found no
striking changes in subcellular localization or expression levels
of lipin1 in nerves of raptor mutants compared to controls. These
results together point to substantial differences between
Schwann cells and other cell types in terms of mTOR-dependent
SREBP signaling, a notion further corroborated by our findings
that mTORC2 deficiency in Schwann cells did not have a detect-
able impact on SREBP signaling, in contrast to reports from
other cell types (Hagiwara et al., 2012; Yuan et al., 2012).
Our analysis of expression levels of factors involved in SREBP
processing, including SCAP, INSIG1, INSIG2, and the proteases
S1P and S2P, did not provide evidence for decreased process-
ing of SREBPs in raptor mutant nerves. On the contrary, the
transcript levels of INSIG1, a translocation inhibitor of the
SCAP-SREBP complex from ER to Golgi, were even reduced,
consistent with Insig1 being a SREBP target gene and part of a
feedback mechanism controlling SREBP levels (Gong et al.,
2006). The parallel decrease of INSIG2 was unexpected, how-
ever, because it is not a SREBP target gene (Yabe et al., 2002).
The promoter of Insig2 carries a functional vitamin D response
element (VDRE) that binds vitamin D receptor (VDR)-RXR heter-
odimers (Lee et al., 2005). Thus, it is conceivable that RXRg
(reduced in raptor mutants) is positively regulating INSIG2
expression in Schwann cells, similar to the SREBP-INSIG1 feed-
back loop.
Although SREBP1c regulates its own transcription via SRE
binding sites in its promoter (Horton et al., 2003), and hence
any defective process affecting SREBP1c activity may decrease
SREBP1c transcription, the highly reduced transcript levels of
SREBP1c in raptor mutants suggested potential involvements
of additional regulating factors in Schwann cells downstream of
mTORC1 signaling. Our search for such candidates revealed a
striking downregulation of the retinoid X receptor RXRg in raptor
mutant nerves. This finding was of particular interest because
loss of RXRg in oligodendrocytes inhibits CNS remyelination by
disturbing oligodendrocyte differentiation (Huang et al., 2011).
In support of functional consequences of the reduced RXRg
levels in raptor mutant nerves, knockdown of RXRg in cultured
Schwann cells causeddownregulation of SREBP1c and its target
SCD1, but not of SREBP2 or its target IDI1. This mirrors the find-
ings of raptor knockdown, with the exception of IDI1 expression,
which was reduced both in raptor knockdown cells and in raptor
mutant nerves, likely due to missing mTORC1-mediated post-Ctranscriptional regulation of SREBP2 activity. Conversely, over-
expression of RXRg increased the levels of both SREBP1c and
its target FASN, whereas SREBP2 and IDI1 remained un-
changed. Moreover, luciferase reporter assays showed that
RXRg activates the SREBP1c promoter, but not the SREBP2
promoter, in cultured primary Schwann cells. Together, these re-
sults indicate that RXRg regulates SREBP1c (but not SREBP2)
expression in Schwann cells downstream of mTORC1. Upregu-
lation of RXRg expression, together with other RXR and RAR re-
ceptors, have been observed in Schwann cell-dorsal root ganglia
neuron (SC-DRGN) cocultures upon induction of myelination (La-
tasa et al., 2010). Moreover, downregulation of RXRg mRNA
levels in both Schwann cells and SC-DRGN cocultures by the
RXR ligand retinoic acid was concomitant with inhibition of mye-
lination in SC-DRGN cocultures (Latasa and Cosgaya, 2011; La-
tasa et al., 2010). These data are consistent with our hypothesis
that mTORC1 controls myelination through RXRg-mediated
SREBP1c regulation. The question remains, however, of how
RXRg is regulated by mTORC1. Retinoic-acid-dependent down-
regulation of RXRg in Schwann cells is likely mediated via RAR
receptors (Latasa and Cosgaya, 2011), and RARa was identified
as a phosphoprotein downstream of mTOR in a screen for
mTORC1 substrates (Yu et al., 2011). Thus, RARphosphorylation
downstream of mTORC1 might be required for its regulation of
RXRg. However, because no putative RAR binding elements
were found in the Rxrg promoter, such a regulation is unlikely
to be direct (Latasa and Cosgaya, 2011).
In conclusion, we show that mTOR signaling, specifically
mediated by mTORC1, is a central regulator of PNS myelina-
tion, axonal growth, and lipid metabolism. Because dysregula-
tion of the mTOR pathway has been implicated in hereditary
peripheral neuropathies (Goebbels et al., 2012) and is likely to
play important regulatory roles in neuropathies associated
with metabolic disorders, our results also provide significant




Mutant mice were obtained by crossing mice with floxed alleles of raptor and/
or rictor (Bentzinger et al., 2008; Polak et al., 2008) with mice expressing Cre
under the Dhh promoter (Jaegle et al., 2003). Littermates lacking Cre were
used as controls. Nerves from S6K1//S6K2/ mice were a gift from Mario
Pende (Pende et al., 2004). Animal experiments were approved by the Veter-
inary Office of the Canton of Zurich, Switzerland.
Histology and Immunohistochemistry
Microscopy of sciatic nerves was performed as described (Pereira et al.,
2010); see Supplemental Experimental Procedures for details, including anti-
bodies used.
Biochemistry
Western blotting and quantitative RT-PCR (qRT-PCR) were performed from
epineurium-stripped sciatic nerves according to standard protocols; see Sup-
plemental Experimental Procedures for details, including antibodies and
primer sequences.
Lentivirus Generation
To generate overexpression lentivirus, the coding region of mouse Rxrg
(NM_009107.3) was cloned into a pCCLsin.PPT.hPGK.PRE lentiviralell Reports 9, 646–660, October 23, 2014 ª2014 The Authors 657
backbone. The hPGK promoter was replaced by a 1.1 kb fragment of the rat P0
promoter (Messing et al., 1992). For virus production, HEK293T cells were
transfected with viral constructs and packaging plasmids using Lipofectamine
2000 (Invitrogen).
Cell-Culture Analyses
Primary rat Schwann cells (used in all experiments) were obtained as
described (Jacob et al., 2008). For knockdown studies, cells were transfected
with pools of two siRNAs for each target (ON-TARGET plus siRNA, Thermo
Scientific) using DharmaFECT transfection reagent (Thermo Scientific). ON-
TARGET plus nontargeting siRNA was used as control. Three days after trans-
fection, cells were lysed with Qiazol lysis reagent and analyzed by qRT-PCR.
For overexpression experiments, cells were transduced with RXRg-overex-
pressing lentivirus or GFP-expressing control virus. Three days later, cells
were analyzed using qRT-PCR. For luciferase assays, cells were transfected
with a pGL3-Basic firefly luciferase vector containing the full-length rat
SREBP1c promoter (1.5 kb) (Deng et al., 2002), a pGL2-Basic firefly luciferase
vector containing the mouse SREBP2 promoter (4316) (Shin and Osborne,
2003), or the corresponding vector backbones without the promoter se-
quences. A Renilla luciferase vector was used as an internal control. Five hours
later, cells were transduced with RXRg-overexpressing lentivirus or GFP-ex-
pressing control virus, and after 3 days cells were assayed for luciferase activ-
ity using Dual-Luciferase Reporter Assay System (Promega).
Lipid Analysis
For lipid profiling, sciatic nerves from P60mice were stripped from the epineu-
rium, and lipids were extracted and analyzed using mass spectrometry as pre-
viously described (Lebrun-Julien et al., 2014). See Supplemental Experimental
Procedures for details.
Electrophysiology
NCV were measured in 4-month-old anesthetized mice as described (Bremer
et al., 2010). Briefly, upon stimulation of the tibial nerve at the ankle (‘‘distal’’)
and of the sciatic nerve at the sciatic notch (‘‘proximal’’), compound muscle
action potentials (CMAPs), measuring motor NCV, were recorded from the
foot muscle. Motor NCV (mNCV) was calculated from the difference between
distal and proximal latencies. Compound sensory nerve action potentials,
measuring compound sensory NCV (csNCV), were recorded from the proximal
sciatic nerve after stimulating the tibial nerve at the ankle, similarly as in the
motor conduction studies.
Statistical Analysis
Data are shown as mean ± SEM. Statistical significance was determined using
a two-tailed Student’s t test. Significance was set at *p < 0.05, **p < 0.01, and
***p < 0.001. N refers to the number of independent animals analyzed unless
indicated differently.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2014.09.001.
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